HNRNPC and central nervous system cancer: To further elucidate the correlation of HNRNPC expression with prognosis of glioma patients, univariate analysis demonstrated that the clinical stage (HR = 2.508, 95% CI = 1.450–4.338, and p = 0.001) and HNRNPC expression level (HR = 0.510, 95% CI = 0.282–0.923, and p = 0.026) were associated with prognosis.